Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Global demand for macular degeneration treatment market was valued at approximately USD 6.38 billion in 2018, and is expected to generate revenue of around USD 10.07 billion by end of 2025, growing at a CAGR of around 6.8% between 2019 and 2025.

29-Nov-2019 | Number of pages: 110 | Report Code: ZMR-5117 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degeneration treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the macular degeneration treatment market on a global as well as regional level.

According to the report, global demand for macular degeneration treatment market was valued at approximately USD 6.38 billion in 2018, and is expected to generate revenue of around USD 10.07 billion by end of 2025, growing at a CAGR of around 6.8% between 2019 and 2025.

In order to give the users of this report a comprehensive view on the macular degeneration treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the macular degeneration treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new drug class launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the macular degeneration treatment market on global and regional basis.

The study provides a crucial view on the macular degeneration treatment by segmenting the market based on drug class, indication, distribution channel and region. All the segments of macular degeneration treatment market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Macular degeneration is one of major eye disorder and a leading cause of vision loss, affecting people more than cataracts and glaucoma together. Currently, macular degeneration cannot be cured i.e. it is an incurable disease. Deterioration of central portion of the retina called macula leads to macular degeneration. Retina records images we see and signal is sent to brain via optic nerve. Macula is responsible for central vision focusing in the eye. Macula also controls our ability to recognize colors or faces, ability to read, and see objects with fine details.

The demand for macular degeneration treatment market is driven by increasing prevalence of eye disorders, age related macular degeneration and increasing geriatric population across the globe. Additionally, focus of major pharmaceutical manufacturers on development of novel treatment options, increasing awareness, government initiatives to support R&D, and increasing healthcare spending are other factors that boost the market growth. However, growing off-label use of products may hamper the market growth. Emerging markets with unmet medical needs and increasing geriatric population are expected to bring new growth avenues for major market players working in the global macular degeneration treatment.

Based on drug class, global macular degeneration treatment market is bifurcated into anti-vascular endothelial growth factor (VEGFs), and other drugs. Anti-VEGFs accounted for largest market share in 2018 and are projected to witness rapid CAGR over the forecast period as they are considered as gold standard therapy for macular degeneration.

Based on indication market is segmented into Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD). wAMD indication segment accounted for largest market share in 2018 due to large number of ongoing research activities for novel therapy development for wAMD. Favorable reimbursement policies may further boost this growth over the forecast period.

The distribution channel segment is divided ambulatory surgical centers, ophthalmic clinics and hospitals. Hospitals dominated the macular degeneration treatment market to ease of access to hospitals and availability of technologically advanced facilities. Ophthalmic clinics are projected to witness rapid growth over the forecast period.

North America dominated the global macular degeneration treatment market in 2018. Increasing prevalence of eye disorders, increasing geriatric population, favorable reimbursement policies, and growing awareness are factors driving the market in this region. Europe was second largest regional market. Availability of developed infrastructure, increasing awareness and prevalence of eye disorders are some of the factors that fuel market growth in this region. Latin America is projected to witness moderate growth over the forecast period. Asia Pacific region is estimated to witness highest CAGR for macular degeneration treatment market in the coming years. Increasing prevalence of age related macular degeneration in geriatric population, increasing disposable income, health care spending, and growing awareness are factors promoting macular degeneration treatment market growth in Asia Pacific. Middle East and Africa will see considerable growth in coming years.

Major players included in the report are Valeant Pharmaceuticals, Santen Pharmaceuticals, Pfizer, Inc., Sanofi, F. Hoffmann-La Roche, StemCells, Neurotech Pharmaceuticals, Ophthotech Corporation, Bayer AG, GlaxoSmithKline, Allergan and Novartis among others.

The report segment of global macular degeneration treatment market as follows:

Global Macular Degeneration Treatment Market: By Drug Class

  • Anti-vascular Endothelial Growth Factor (VEGFs)
  • Other Drugs

Global Macular Degeneration Treatment Market: By Indication

  • Wet Age-related Macular Degeneration (wAMD)
  • Dry Age-related Macular Degeneration (dAMD)

Global Macular Degeneration Treatment Market: By Distribution Channel

  • Ambulatory Surgical Centers
  • Ophthalmic Clinics
  • Hospitals

Global Macular Degeneration Treatment Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Dexamethasone Market by Formulation type (liquid, Tablet, Solution for injection, Other), by Patient type (Adult, Pediatric, and Geriatric), by Application (Anti-inflammatory and immunosuppressant effects, Respiratory Distress Syndrome, COVID-19, and Others), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5369 | Report Format:

The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Dexamethasone market alo...Read More

Over-the-Counter Drugs Market by Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5362 | Report Format:

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counte...Read More

Remdesivir Market by Dosage (2.5mg, 5mg, 100mg, 200mg), by Patient (Adult, Pediatric, and Geriatric), by Application (Ebola, SARS-COV, MERS-COV, COVID-19), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5358 | Report Format:

The report covers forecast and analysis for the Remdesivir market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Remdesivir market along wit...Read More

Immunity Booster Market - by Nature (Organic, Conventional), by Source (Plant-based, Animal-based, Other), by Form (Tablets, Capsules, Powder, Liquid), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacy & Drug Stores, and Online Retail) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5357 | Report Format:

The report covers forecast and analysis for the Immunity booster market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Immunity booster mark...Read More

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.